Goldman Sachs Lowers Numbers On ArvinMeritor (ARM), But Still Sees Growth Above Average

February 2, 2011 8:55 AM EST Send to a Friend
Goldman Sachs trimmed 2011/2012 EBITDA estimates and its price target on Neutral-rated ArvinMeritor (NYSE: ARM).

2011 EBITDA estimates ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login